Jun 07, 2023 / 12:30PM GMT
Mike Sarcone - Jefferies LLC - Analyst
You can kick this off. Good morning, everyone, and welcome to day one of the Jefferies 2023 Healthcare Conference. My name is Mike Sarcone. I'm an analyst on the medical supplies and devices team.
And we're happy to kick off the med devices track today with Axogen. They're a leader in peripheral nerve repair. And from the company, we've got Karen Zaderej, Chairwoman, CEO, and President; and Pete Mariani, CFO. Karen and Pete, thanks for joining us today.
Karen Zaderej - Axogen, Inc. - Chairman, CEO & President
Thank you, Mike.
Pete Mariani - Axogen, Inc. - EVP & CFO
Thanks.
Questions and Answers:
Mike Sarcone - Jefferies LLC - AnalystGreat. So I guess just to kick off, just talking about recent performance, Axogen has posted mid to high teens growth in the last three quarters. And that includes 18% growth in 1Q. You maintained your 11% to 15% top-line sales growth guidance for 2023.
I guess, can you